Opzelura Experience Study

Starting soon · Phase 4

Conditions studied: Atopic Dermatitis

In brief

Atopic dermatitis is a common multifactorial skin disease. Topicals are the mainstay of treatment, but adherence to topicals is often abysmal, possibly worsened by the complexity of recommended treatment algorithms. Giving patients a simple, one drug approach may be advantageous.

Key facts

Study ID

NCT07661979

Run by

Wake Forest University Health Sciences

People needed

50

Starts

2026-08-01

Expected to finish

2027-10-01

Last updated by the study team

2026-07-14

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients ≥2 years of age
• Patients with a current diagnosis of atopic dermatitis that is mild-to-moderate in severity and in ≥2 body areas
• Patients with up to 20% total body surface area involvement
• Women of childbearing age taking/using a contraceptive

You may not qualify if…

• Patients without a current diagnosis of atopic dermatitis
• Patients who are prescribed changing systemic medications or treatments (phototherapy, biologics) for atopic dermatitis
• Patients who would require use of other topical medications for other diagnoses (tretinoin, clindamycin)
• Patients with areas of skin with active infection
• Patients who are pregnant

Where it is running

• Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.